LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
29 funds hold it · Insiders net selling
Net selling: insiders sold $337K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 5, 2026
Period ending
Sep 30, 2026
Earnings per share
$0.16 expected
Estimates as of Nov 11, 2026
EPS expected
$0.20 to $0.20
Revenue expected
6 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Nov 5, 2026 | $0.13est. $0.16 | -16.81%miss | $742.1MSEC filing | +29.5%from $572.9M |
| Jun 30, 2026Reported Aug 6, 2026 | $0.15est. $0.14 | +11.48%beat | $674.3MSEC filing | +24.3%from $542.5M |
| Mar 31, 2026Reported May 7, 2026 | $0.14est. $0.15 | -7.40%miss | $650.8MSEC filing | +20.4%from $540.6M |
| Dec 31, 2025Reported Feb 26, 2026 | $0.14est. $0.15 | -6.28%miss | $604.1MAlpha Vantage | +11.3%from $542.7M |
| Sep 30, 2025Reported Nov 6, 2025 | $0.27est. $0.15 | +80.00%beat | $572.9MSEC filing | +9.4%from $523.8M |
| Jun 30, 2025Reported Aug 7, 2025 | $0.42est. $0.40 | +5.00%beat | $542.5MSEC filing | +7.5%from $504.6M |
| Mar 31, 2025Reported May 8, 2025 | $0.11est. $0.04 | +$0.07beat | $540.6MSEC filing | +8.2%from $499.5M |
| Dec 31, 2024Reported Feb 27, 2025 | -$0.21est. $0.10 | -$0.32miss | $542.7MAlpha Vantage | +12.5%from $482.6M |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $604.1M | $650.8M | $674.3M | $742.1M |
| Cost of what it sold | $480.3M | $512.2M | $681.3M | $577.4M |
| Gross profit | $123.8M | $138.6M | -$7.0M | $164.8M |
| What it spent | ||||
| Sales and admin | $28.7M | $30.7M | $37.50B | $21.6M |
| Other operating costs | $55.3M | $67.1M | -$37.55B | $96.0M |
| Total operating expenses | $84.1M | $97.8M | -$52.6M | $117.6M |
| What was left | ||||
| Operating profit | $39.7M | $40.8M | $45.6M | $47.2M |
| Interest on debt | $19.8M | $18.8M | $18.6M | $17.8M |
| Profit before tax | $8.5M | $23.5M | $31.0M | $32.3M |
| Tax | -$2.4M | -$525.0K | -$3.0K | $740.0K |
| Net profit | $10.8M | $23.7M | $30.6M | $31.2M |
| EBITDA | $92.5M | $118.3M | $130.8M | $140.9M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
If the AI Boom Stalls, What Stocks Should You Buy?
BullishNov 12American Healthcare REIT (NYSE:AHR) Given New $71.00 Price Target at UBS Group
BullishNov 11American Healthcare REIT director Scott Estes sells $148,300 in stock By Investing.com
NeutralNov 11Citigroup maintains American Healthcare REIT at Buy, raises price target to $67 from $65
NeutralNov 11American Healthcare REIT (NYSE:AHR) Director Scott Estes Sells 2,500 Shares of Stock
Leans bullishNov 11Form 4 American Healthcare REIT Inc: Scott A. Estes (Director) For: 10 November
NeutralNov 10Raymond James raises American Healthcare REIT price target on platform strength
BullishNov 10American Healthcare REIT stock hits all-time high at 58.71 USD
BullishNov 933 macro signals shaping AHR right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
